Generic Release Date:

Risvan's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be May 31, 2031 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Risvan Generic API suppliers:

Risperidone is the generic name for the brand Risvan. 39 different companies have already filed for the generic of Risvan, with Heritage Pharma Avet having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Risvan's generic

Alternative Brands for Risvan

There are several other brand drugs using the same active ingredient (Risperidone) as Risvan. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Apart from brand drugs containing the same ingredient, some generics have also been filed for Risperidone, Risvan's active ingredient. Check the complete list of approved generic manufacturers for Risvan

Approval Date:

Risvan was approved by FDA for market use on 29 March, 2024.

Active Ingredient:

Risvan uses Risperidone as the active ingredient. Check out other Drugs and Companies using Risperidone ingredient

Dosage:

Risvan is available in for suspension, extended release form for intramuscular use. Given below is detailed information on Dosage -